Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
bioCSL
Vaccines
Flucelvax, Fluad propel Seqirus to 26% sales growth in H1
Flu vaccine specialist Seqirus grew sales 26% in the six months leading up to Dec. 31, driven by a portfolio shift.
Eric Sagonowsky
Feb 20, 2018 3:32pm
Seqirus investing $52M to UK flu vax site and adding 100 jobs
Nov 9, 2017 9:04am
Flu season early bird Seqirus debuts Fluad campaign
Aug 23, 2017 8:58am
With no FluMist, CDC worries flu vaccination rates could slip
Oct 4, 2016 10:27am
